Please ensure Javascript is enabled for purposes of website accessibility Cir.No.165 of 2025 – Regarding Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Associated with Semaglutide. Cir.No.165 of 2025 – Regarding Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Associated with Semaglutide.

Cir.No.165 of 2025 – Regarding Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Associated with Semaglutide.

Content Details
Pharmacovigilance and drug information Department News and Safety Alerts
Cir.No.165 of 2025 – Regarding Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Associated with Semaglutide.
06/07/2025

Cir.No.165 of 2025 – Regarding Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Associated with Semaglutide.

View Download
3
Cir.No.165 of 2025 – Regarding Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Associated with Semaglutide.
Was this page helpful?
0 visitors liked this page of total 0 visitors
Be the first to evaluate this page

Add Reason (choose at least one)

الرجاء اختيار سببان كحد أعلى

هذا الحقل مطلوب

الرجاء كتابة نص صحيح

الملاحظات يجب ان تكون اقل من ٢٥٠ حرف

Share this page
Follow Us On